Tango Therapeutics, Inc. ($TNGX)
Filing Information
| Accession Number | 0001193125-26-255940 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 3, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
81,000
Total Value
$757,971.27
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D | Common Stock | โ | Jun 1, 2026 | Exercise/Conversion | 27,000 | $5.20 | $140,400.00 | 142,743 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | Jun 1, 2026 | Sale | 6,140 | $22.25 | $136,627.28 | 136,603 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | Jun 1, 2026 | Sale | 20,860 | $23.06 | $480,943.99 | 115,743 | Direct | โ | View Details | |
President, R&D | Stock Option (Right to Buy) | Derivative | Jun 1, 2026 | Exercise/Conversion | 27,000 | $0.00 | $0.00 | 341,040 | Direct | โ | View Details |